The Breast Reconstruction Risk Assessment (BRA) Score is a model developed to predict the risk of surgical site infections (SSI) within 30 days after breast reconstruction. This was derived from the National Surgical Quality Improvement Program (NSQIP) database, where the average risk of SSI was 3.75%. We aim to externally validate this model in our cohort of patients who have undergone total skin-sparing mastectomy (TSSM) with immediate breast reconstruction.
METHODS:
We reviewed all cases of TSSM with immediate breast reconstruction between [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] performed at our institution. SSIs in our cohort were defined as any infections requiring oral antibiotics, intravenous antibiotics, or procedures for resolution. The BRA Score variables included type of reconstruction, age, BMI, ASA class 3+, bleeding disorder, prior PCI or cardiac surgery, diabetes, active smoking, dyspnea, and hypertension. We compared the BRA Score model with models derived from our own dataset. We generated a new model using variables associated with complications after breast reconstruction, including age, BMI, diabetes, incision, lymph node dissection, prior radiation, and acellular dermal matrix.
RESULTS:
We identified 746 patients who had undergone TSSM with immediate breast reconstruction, with an overall 30-day SSI risk of 5.2%. The 1-year SSI risk was 16.4% in the 684 patients who underwent prosthetic breast reconstruction. The BRA Score for 30-day SSI did not fit our data well (C-statistic 0.509). We generated a risk prediction model using specific variables associated with breast reconstruction, and ten-fold cross-validation yielded improved discrimination for overall 30-day risk of SSI (C-statistic 0.583) and 1-year SSI risk in prosthetic breast reconstruction (C-statistic 0.625).
CONCLUSION:
Many risk prediction models have been published, but few are used clinically due to lack of validation or relevance to the population studied. The BRA Score model does not incorporate several important variables associated with breast reconstruction outcomes, such as lymph node dissection status, prior radiation, and the use of acellular dermal matrix. Our new model with these variables achieves better discrimination with our data but requires external validation. An improved SSI risk model could be developed using a larger cohort, with variables specific to breast reconstruction.
P7 The Epidemiology of Surgical Site Infection following Body Contouring Plastic Surgery
Asaf Harofeh Medical Center, Beer Yaakov, Israel PURPOSE: Surgical site infections (SSI) following body contouring plastic surgery (BCPS) poses a significant burden for both patients, caregivers and healthcare system. SSI might lead to undesired surgical outcomes, ranging from unaesthetic surgical scar and prolonged hospitalization up to permanent disability and even death. Reported rate of SSI following BCPS is 2-7%, but is estimated much higher among different subgroups such as massive weight loss patients. Our study objective is to evaluate SSI rate among massive weight loss patients who underwent BCPS and conduct a risk factor and outcomes analysis.
METHODS:
We performed a retrospective cohort study on massive weight loss patients who underwent BCPS between 2007-2014. Data was obtained from both printed and electronic medical records, and a patient questionnaire. The outcome examined was SSI (using the CDC criteria). Logistic regression was conducted according to established methodology and criteria to assess independent risk factors for SSI.
RESULTS:
Eighty-six patients were enrolled, 71 of them were women. Average age was 42.4 ± 12 years. SSI rate was 19.7% (N=17), with average of 9 ± 9 days to infection. Unadjusted SSI risk factors included lifetime maximal weight, lifetime maximal loss of body mass index prior to surgery, and estimated blood loss during surgery. Independent SSI associated factors included gynecomastia repair procedure (OR=13.717, CI 95% 1.06-177, p=0.045), and
